277 related articles for article (PubMed ID: 11377928)
21. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
Pehek EA
J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
[TBL] [Abstract][Full Text] [Related]
22. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.
Moore H; Todd CL; Grace AA
J Neurosci; 1998 Jul; 18(13):5068-77. PubMed ID: 9634572
[TBL] [Abstract][Full Text] [Related]
23. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
Ago Y; Nakamura S; Baba A; Matsuda T
Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
[TBL] [Abstract][Full Text] [Related]
24. Characterization of clozapine-induced changes in synaptic plasticity in the hippocampal-mPFC pathway of anesthetized rats.
Matsumoto M; Shikanai H; Togashi H; Izumi T; Kitta T; Hirata R; Yamaguchi T; Yoshioka M
Brain Res; 2008 Feb; 1195():50-5. PubMed ID: 18201687
[TBL] [Abstract][Full Text] [Related]
25. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
26. Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment.
Youngren KD; Moghaddam B; Bunney BS; Roth RH
Neurosci Lett; 1994 Jan; 165(1-2):41-4. PubMed ID: 8015734
[TBL] [Abstract][Full Text] [Related]
27. Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats.
Hernandez L; Hoebel BG
Pharmacol Biochem Behav; 1995 Nov; 52(3):581-9. PubMed ID: 8545478
[TBL] [Abstract][Full Text] [Related]
28. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
Li XM; Perry KW; Wong DT; Bymaster FP
Psychopharmacology (Berl); 1998 Mar; 136(2):153-61. PubMed ID: 9551772
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine administration does not affect desipramine-induced dopamine levels as measured in vivo in prefrontal cortex.
Bongiovanni R; Kirkbride B; Walmire P; Jaskiw GE
Brain Res; 2005 Aug; 1054(2):203-6. PubMed ID: 16083866
[TBL] [Abstract][Full Text] [Related]
30. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex.
Verma V; Lim EP; Han SP; Nagarajah R; Dawe GS
Neurosci Res; 2007 Jan; 57(1):17-28. PubMed ID: 17028028
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.
Yamamoto BK; Cooperman MA
J Neurosci; 1994 Jul; 14(7):4159-66. PubMed ID: 7913120
[TBL] [Abstract][Full Text] [Related]
32. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion.
Brodnik Z; Double M; Jaskiw GE
Psychopharmacology (Berl); 2013 May; 227(2):363-71. PubMed ID: 23371490
[TBL] [Abstract][Full Text] [Related]
34. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Masana M; Bortolozzi A; Artigas F
Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
[TBL] [Abstract][Full Text] [Related]
35. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats.
Morrow BA; Rosenberg SJ; Roth RH
Synapse; 1999 Oct; 34(1):28-35. PubMed ID: 10459169
[TBL] [Abstract][Full Text] [Related]
36. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
37. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
[TBL] [Abstract][Full Text] [Related]
38. Brain region effects of clozapine on amino acid and monoamine transmission.
Yamamoto BK; Pehek EA; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():8-14. PubMed ID: 7961581
[TBL] [Abstract][Full Text] [Related]
39. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action.
Díaz-Mataix L; Scorza MC; Bortolozzi A; Toth M; Celada P; Artigas F
J Neurosci; 2005 Nov; 25(47):10831-43. PubMed ID: 16306396
[TBL] [Abstract][Full Text] [Related]
40. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.
Heidbreder CA; Foxton R; Cilia J; Hughes ZA; Shah AJ; Atkins A; Hunter AJ; Hagan JJ; Jones DN
Psychopharmacology (Berl); 2001 Jul; 156(2-3):338-51. PubMed ID: 11549234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
